{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T13:54:19Z","timestamp":1793109259433,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","award":["R\/Dev\/D\/IoE\/Incentive\/2021-22\/32449"],"award-info":[{"award-number":["R\/Dev\/D\/IoE\/Incentive\/2021-22\/32449"]}],"id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000312","name":"Joseph Rowntree Foundation","doi-asserted-by":"publisher","award":["211610156180"],"award-info":[{"award-number":["211610156180"]}],"id":[{"id":"10.13039\/501100000312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ejphar.2025.177361","type":"journal-article","created":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T02:36:23Z","timestamp":1738982183000},"page":"177361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Synergistic combination of doxorubicin with fisetin for the treatment of lymphoma"],"prefix":"10.1016","volume":"992","author":[{"given":"Sumeet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinita","family":"Gouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplob","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-2421","authenticated-orcid":false,"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.177361_bib1","doi-asserted-by":"crossref","first-page":"6393","DOI":"10.3390\/ijms24076393","article-title":"Antiproliferative mechanisms of a polyphenolic combination of kaempferol and fisetin in triple-negative breast cancer cells","volume":"24","author":"Afzal","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.177361_bib2","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12935-023-03052-z","article-title":"Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review","volume":"23","author":"Asnaashari","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2025.177361_bib3","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.177361_bib4","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.177361_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.ejphar.2025.177361_bib6","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","article-title":"Targeting apoptosis in cancer therapy","volume":"17","author":"Carneiro","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2025.177361_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/acel.12185","article-title":"Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice","volume":"13","author":"Currais","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.ejphar.2025.177361_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2019.00697","article-title":"New perspectives for fisetin","volume":"7","author":"Grynkiewicz","year":"2019","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejphar.2025.177361_bib9","article-title":"The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: focus on the role of oxidative stress","volume":"13","author":"Hassan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177361_bib10","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2174\/1568026620666200502005411","article-title":"Research progress in flavonoids as potential anticancer drug including synergy with other approaches","volume":"20","author":"Hussain","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2025.177361_bib11","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2025.177361_bib12","doi-asserted-by":"crossref","first-page":"9357","DOI":"10.1074\/jbc.273.16.9357","article-title":"Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis","volume":"273","author":"J\u00e4nicke","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.177361_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/ars.2012.4901","article-title":"Fisetin: a dietary antioxidant for health promotion","volume":"19","author":"Khan","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejphar.2025.177361_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5381692","article-title":"Understanding of ROS-inducing strategy in anticancer therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ejphar.2025.177361_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12935-016-0288-3","article-title":"Paclitaxel and the dietary flavonoid fisetin: a synergistic combination that induces mitotic catastrophe and autophagic cell death in A549 non-small cell lung cancer cells","volume":"16","author":"Klimaszewska-Wisniewska","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejphar.2025.177361_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/ph16020196","article-title":"Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics","volume":"16","author":"Kumar","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejphar.2025.177361_bib17","doi-asserted-by":"crossref","first-page":"10266","DOI":"10.1021\/acs.jpcb.3c02382","article-title":"Density functional theory-guided photo-triggered anticancer activity of curcumin-based zinc(II) complexes","volume":"127","author":"Kushwaha","year":"2023","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ejphar.2025.177361_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.808480","article-title":"Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through SIRT1\/nrf2 signaling pathway activation","volume":"12","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177361_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.808480","article-title":"Fisetin attenuates doxorubicin-induced cardiomyopathy in vivo and in vitro by inhibiting ferroptosis through SIRT1\/nrf2 signaling pathway activation","volume":"12","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177361_bib20","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1002\/ptr.7855","article-title":"Fisetin attenuates doxorubicin-induced cardiotoxicity by inhibiting the insulin-like growth factor II receptor apoptotic pathway through estrogen receptor-\u03b1\/-\u03b2 activation","volume":"37","author":"Lin","year":"2023","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejphar.2025.177361_bib21","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11033-018-4450-y","article-title":"Fisetin, a plant flavonoid ameliorates doxorubicin-induced cardiotoxicity in experimental rats: the decisive role of caspase-3, COX-II, cTn-I, iNOs and TNF-\u03b1","volume":"46","author":"Ma","year":"2019","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2025.177361_bib22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.rcl.2008.03.005","article-title":"Overview of lymphoma diagnosis and management","volume":"46","author":"Matasar","year":"2008","journal-title":"Radiologic Clinics of North America, Imaging of Lymphoma"},{"key":"10.1016\/j.ejphar.2025.177361_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101205","article-title":"Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming","volume":"93","author":"Mattioli","year":"2023","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.ejphar.2025.177361_bib24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.ejphar.2025.177361_bib25","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/febs.14186","article-title":"Bax, Bak and beyond \u2014 mitochondrial performance in apoptosis","volume":"285","author":"Pe\u00f1a-Blanco","year":"2018","journal-title":"FEBS J."},{"key":"10.1016\/j.ejphar.2025.177361_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejphar.2025.177361_bib27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejphar.2011.07.021","article-title":"Modulatory effects of fisetin, a bioflavonoid, on hyperglycemia by attenuating the key enzymes of carbohydrate metabolism in hepatic and renal tissues in streptozotocin-induced diabetic rats","volume":"668","author":"Prasath","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177361_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s43188-022-00158-w","article-title":"Assessment of toxicity and genotoxic safety profile of novel fisetin ruthenium-p-cymene complex in mice","volume":"39","author":"Seal","year":"2023","journal-title":"Toxicol. Res."},{"key":"10.1016\/j.ejphar.2025.177361_bib29","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejphar.2025.177361_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105484","article-title":"Aqua-(2-formylbenzoato)triphenyltin(IV) induces cell cycle arrest and apoptosis in hypoxic triple negative breast cancer cells","volume":"86","author":"Singh","year":"2023","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.ejphar.2025.177361_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119527","article-title":"A comprehensive review on time-tested anticancer drug doxorubicin","volume":"278","author":"Sritharan","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.177361_bib32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/biof.1577","article-title":"Fisetin, a phytopolyphenol, targets apoptotic and necroptotic cell death in HepG2 cells","volume":"46","author":"Sundarraj","year":"2020","journal-title":"Biofactors"},{"key":"10.1016\/j.ejphar.2025.177361_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2023.113308","article-title":"Evaluation of methotrexate encapsulated polymeric nanocarrier for breast cancer treatment","volume":"226","author":"Verma","year":"2023","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.ejphar.2025.177361_bib34","first-page":"1","article-title":"Advances in targeted therapy for malignant lymphoma","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2025.177361_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1756-9966-30-87","article-title":"Apoptosis in cancer: from pathogenesis to treatment","volume":"30","author":"Wong","year":"2011","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2025.177361_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.phymed.2018.01.009","article-title":"Recent progress in doxorubicin-induced cardiotoxicity and protective potential of natural products","volume":"40","author":"Yu","year":"2018","journal-title":"Phytomedicine"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:00:04Z","timestamp":1777417204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"alternative-id":["S0014299925001141"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177361","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synergistic combination of doxorubicin with fisetin for the treatment of lymphoma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177361"}}